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Abstract
Background: Rotavirus is the leading cause of acute gastroenteritis (AGE) and the most frequent cause of severe
diarrhoea in children aged less than 5 years. Although the epidemiology of rotavirus gastroenteritis (RVGE) is well
documented, there are few data on the impact of RVGE on the families of affected children.
Methods: Data associated with the burden of RVGE, including number of working days lost, levels of parental
stress, the need for alternative childcare arrangements and additional nappies used, were extracted from
questionnaires completed by parents of children participating in a prospective, multicentre, observational study
(Rotavirus gastroenteritis Epidemiology and Viral types in Europe Accounting for Losses in public health and
society, REVEAL), conducted during 2004-2005 in selected areas of Belgium, France, Germany, Italy, Spain, Sweden,
and the United Kingdom to estimate the incidence of RVGE in children aged less than 5 years seeking medical
care as a result of AGE.
Results: 1102 children with RVGE were included in the present analysis. The proportion of RVGE cases that
required at least one parent or other person to be absent from work was 39%-91% in the hospital setting, 44%-
64% in the emergency department, and 20%-64% in primary care. Self-reported levels of parental stress were
generally high (mean stress levels, ≥ 5 on a 10-point visual analogue scale). Additional childcare arrangements
were required in up to 21% of RVGE episodes. The mean number of nappies used per day during RVGE episodes
was approximately double that used when the child was not ill.
Conclusions: Paediatric RVGE cases cause disruption to families and parental stress. The burden of RVGE on
children and their families could be substantially reduced by routine rotavirus vaccination of infants.
Background
Rotavirus is the leading cause of acute gastroenteritis
(AGE) and the most frequent cause of severe diarrhoea
in children aged less than 5 years [1,2]. Although the
epidemiology of and health-care costs associated with
RVGE are well documented, there are few data on the
impact of RVGE on the families of affected children.
It is estimated that RVGE is the cause of 611,000
deaths annually in children aged less than 5 years [3], of
which approximately 230 occur in the European Union
[4]. Although mortality due to RVGE is relatively low in
industrialized regions, diarrhoea remains a common
cause of physician visits and hospital admissions in chil-
dren aged less than 5 years [1,5]. Moreover, the peak
incidence of RVGE occurs between January and March
[2,6,7], which coincides with the peak incidences of
other infections, such as respiratory-tract infections
caused by respiratory syncytial virus or influenza virus.
The high rate of hospitalisation associated with RVGE
at this time of year can place a considerable additional
burden on hospital services [8].
The Rotavirus gastroenteritis Epidemiology and Viral
types in Europe Accounting for Losses in public health
and society (REVEAL) study is a prospective, 1-year * Correspondence: giaquinto@pediatria.unipd.it
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October 2004 and September 2005 using a common
protocol in selected areas of Belgium, France, Germany,
Italy, Spain, Sweden and the UK. The aims of this study
were to determine the incidence and burden of RVGE
in children aged less than 5 years with AGE and seeking
medical attention in a primary-care, emergency or hos-
pital setting. Full details of the study design and sam-
pling procedures have been reported previously [2]. The
study also described the distribution of rotavirus sero-
types [9], the clinical impact [10] and the economic and
societal costs of RVGE in these seven countries [11]. A
total of 2846 children with AGE were included in the
study. The number of children included in each study
area varied from 127 children in Belgium to 801 chil-
dren in Spain; the majority of the children in all coun-
tries and settings were younger than 2 years of age [2].
The results of tests for rotavirus by enzyme-linked
immunosorbent assay (ELISA) were available for 2712
children. Overall, ELISA results were positive for 1102
children (40.6%) [9], ranging from 33% in Germany and
Spain to 59% in Sweden. The percentages of children
with AGE who were found to be rotavirus positive ran-
ged from 53% in Spain to 69% in Italy for hospitalised
children, from 35% in Spain to 64% in Sweden for those
seen in emergency departments, and from 7% in Sweden
to 41% in Belgium for those seen in primary-care
settings.
Morbidity associated with this illness has been shown
to be a substantial burden for children, health-care pro-
viders and society in Europe [10-13]. Here we report
data on the burden of paediatric community-acquired
RVGE on family life, collected as part of the REVEAL
study.
Methods
We analysed data collected during the REVEAL study.
Full details of this prospective, multicenter, study,
including design and sampling procedures, have been
reported previously [2]. In brief, the REVEAL Study was
an observational study of AGE in children <5 years of
age in selected areas of 7 European countries. Data were
collected and analyzed for each country for a 12-month
period. The study determined the annual incidence rates
f o rA G Ea n dR V G Ei nc h i l d r e n< 5y e a r so fa g ei np r i -
mary care, emergency department, and hospital settings
in a specific study area in each country, using the same
protocol. Children were excluded if no written consent
was obtained or if they were not native speakers of the
language spoken in the country or if they had no tele-
phone access. The study was conducted in accordance
with the 2004 amendment of the Declaration of Hel-
sinki, the guidelines for Good Epidemiological Practice
[14], and local regulatory requirements. The protocol
was approved by the local ethics committee in each
study area.
The present study included all children from the
REVEAL study with ELISA-confirmed RVGE (n =
1102). This included 57 children from the study areas
in Belgium, 99 from France, 158 from Germany, 336
from Italy, 252 from Spain, 124 from Sweden, and 76
from the UK. Parents of the participating children
completed a follow-up questionnaire relating to para-
meters associated with the burden of AGE, including:
the number of working days lost by parents or other
persons; the need for alternative childcare arrange-
ments (e.g. baby sitters, other family members); the
number of nappies usually used when the child was
healthy and the total number of nappies used from the
onset of the illness to the end of symptoms (excluding
any time the child was in hospital); and self-reported
levels of stress experienced by parents during the ill-
ness, with the intensity of stress ranked on a 10-point
visual analogue scale where 1 = no stress experienced
and 10 = felt extremely stressed [2]. The parents were
required to return the completed questionnaire to the
investigator within 14 days after the onset of symptoms
of AGE.
Statistical analyses were performed using SAS software
(version 8.2; SAS Institute).
Results
The overall response rate in the REVEAL study was
g e n e r a l l yv e r yh i g h ;9 8 %o ff o l l o w - u pq u e s t i o n n a i r e s
were completed and retrieved from parents of children
with AGE in the selected regions of France (274/281),
89% in the German regions (443/498), 97% in Italy
(731/757), 93% in Spain (740/799), and 89% in Sweden
(202/220). However, lower response rates were seen in
the UK study areas (102/160; 64%) and Belgium (82/
127; 65%).
Working days lost
Across all settings and study areas, the proportion of
RVGE cases that required at least one parent or other
person to be absent from work ranged from 39% to 91%
of cases in the hospital setting, from 44% to 64% of
cases in the emergency-department setting, and from
20% to 64% of cases in the primary-care setting
(Table 1). The countries in which a person other than
the child’s parents was most likely to lose time from
work were Belgium, Spain and the UK.
The mean number of working days lost by parents or
other persons caring for children with RVGE ranged
from 2.3 days (hospital, France) to 7.5 days (primary
care, UK) (Table 2). In general, mothers were absent
from work for approximately twice as long as fathers
(data not shown).
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Across study areas, additional childcare arrangements
(e.g. because of exclusion of the child from collective
childcare) were required in up to 21% of RVGE episodes
(hospital, Sweden; Table 3). The need for additional
childcare was identified with a general question that
asked whether anyone was hired specifically to assist
with care of the child during the RVGE episode. The
mean duration of additional childcare ranged from 1.31
days (hospital, Sweden) to 7 days (hospital, France)
(Table 3). No additional childcare was required for chil-
dren with RVGE hospitalized in Spain or for those man-
aged by the emergency department in the UK.
Use of nappies
The mean number of nappies used per day during an
episode of RVGE was approximately double that used
when the child was not ill. Across all countries and set-
tings for children with RVGE, the mean number ± stan-
dard deviation (SD) of nappies used per day ranged
from between 4.22 ± 1.67 (hospital, Germany) and
5.65 ± 2.96 (hospital, Spain) when the child was healthy,
to between 8.76 ± 1.95 (primary care, France) and
12.77 ± 4.72 (hospital, Spain) while the child was ill
(data not shown).
Parental stress
The self-reported levels of parental stress during the
episode of RVGE were generally high. With few excep-
tions across settings and study areas, the mean stress
levels reported by both parents were 5 or more on the
10-point visual analogue scale (Table 4). With the
exception of cases managed in the emergency depart-
ment in Belgium (n = 5), where the mean levels of stress
were the same for both parents, the mean level of stress
reported by mothers was higher than that for fathers
(Table 4). In general, mean levels of parental stress were
lower for children treated in the emergency department
or in a primary-care setting than in hospital, although
this was not the case for Italian mothers or Swedish
fathers of children treated in the emergency department,
or for Swedish parents or UK fathers of children mana-
ged in primary care (Table 4).
Discussion
To our knowledge, the REVEAL study is the first large-
scale European study to document the impact of RVGE
on family life [2]. Our results suggest that RVGE places
a considerable burden on the family of the affected
child. In 39-91% of all RVGE cases, according to health-
Table 1 Percentage of cases of rotavirus-positive gastroenteritis (RVGE) that required at least one parent or other
person to be absent from work
Study area Cases of RVGE requiring at least one parent or other person to be absent from work
Hospital Emergency department Primary care
% n/N % n/N % n/N
Belgium 39 11/29 50 1/2 64 9/14
France 43 13/30 44 22/50 42 8/19
Germany 53 17/32 –
a –
a 36 36/99
Italy 81 43/55 64 94/147 44 55/125
Spain 68 30/46 44 41/96 32 30/94
Sweden 73 46/63 58 29/51 100
b 1/1
b
United Kingdom 91 20/22 50 8/16 20 2/10
aIn the German study area, all eligible children who presented to the emergency department with RVGE during the study were referred to the hospital, so there
were no inclusions for the emergency department setting.
bOnly one child with RVGE was included from the primary-care setting in Sweden; both parents lost at least 1 day from work.
Table 2 Mean number of working days lost by parents or
another person due to their child’s rotavirus-positive
gastroenteritis
a
Study area Mean number of working days lost (standard
deviation)
Hospitalised
cases
Emergency
cases
Primary-care
cases
Belgium 4.2 (2.9) 4.00 4.8 (4.9)
France 2.3 (2.7) 2.5 (1.5) 3.4 (2.1)
Germany 6.4 (2.5) —
b 5.3 (2.9)
Italy 5.4 (3.8) 3.8 (2.8) 3.7 (2.6)
Spain 4.6 (2.2) 4.4 (4.5) 4.1 (3.4)
Sweden 3.8 (2.6) 4.3 (3.0) 5.0
c
United
Kingdom
4.0 (2.7) 2.9 (3.0) 7.5 (6.4)
aThe data given in this table are derived from the same population as in
Table 1, and thus the denominators ‘N’ for each setting are the same as given
in Table 1.
bIn Germany, all eligible children who presented to the emergency
department with RVGE during the study were referred to the hospital, so
there were no inclusions for the emergency-department setting.
c Only one child with RVGE was included from the primary-care setting in
Sweden.
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absent from work. The mean number of working days
lost ranged between 2 and 7 days, and approximately
one quarter of episodes of RVGE required additional
childcare for a mean of up to 7 days. In addition, the
number of nappies used per day during episodes of
RVGE was approximately double that used when the
child was healthy. As might be expected, parents
reported high levels of stress as a result of their child’s
illness.
With regard to the parameters considered in the pre-
sent analysis, the data extracted from the REVEAL study
do have some limitations. First, only children seeking
health care were included in the study and, due to the
inclusion criteria, not all cases of RVGE in the study
area were included. However, we believe it is reasonable
to assume that non-included cases would have similar
characteristics [2]. Second, the analyses reported here
rely on data collected via questionnaires that the parents
completed retrospectively after the child had recovered
from the RVGE episode, raising the potential for bias
due to a number of different factors. For example, there
may have been incomplete or inaccurate recall of the
amount of time lost from work or levels of stress experi-
enced during the child’s illness. In addition, parents who
felt more stressed during the episode of illness might
have been more likely to complete and return the fol-
low-up questionnaire. A further potential weakness is
that the reported levels of parental stress associated with
the RVGE episode were subjective assessments provided
by the parents on a single occasion, although a visual
analogue scale is a well-accepted tool for collecting such
information. Furthermore, the exclusion criteria (no tel-
ephone access, not native speakers of local language)
may have led to some bias in some results. Finally, only
a small number of cases were included in some settings,
Table 3 Percentage of cases for which additional childcare was sought during episodes of rotavirus-positive
gastroenteritis (RVGE) and mean duration of additional childcare
a
Study area Cases of RVGE requiring at least one parent or other person to be absent from work
Hospital Emergency department Primary care
% of cases (n) Mean duration (days) % of cases (n) Mean duration (days) % of cases (n) Mean duration (days)
Belgium 7.4 (2) 4.00 0 0 7.1 (1) 5.00
France 3.3 (1) 7.0 0 0 0 0
Germany 00 –
b –
b 6.1 (6) 4.08
Italy 4.0 (2) 3.50 5.3 (7) 2.86 8.5 (10) 3.00
Spain 0 0 3.3 (3) 4.83 3.2 (3) 4.67
Sweden 21.3 (13) 1.31 14.0 (7) 2.86 0
c 0
c
United Kingdom 14.3 (3) 3.00 0 0 11.1 (1) 3.00
aThe data given in this table are derived from the same population as in Table 1, and thus the denominators ‘N’ for each setting are the same as given in Table 1.
bIn Germany, all eligible children who presented to the emergency department with RVGE during the study were referred to the hospital, so there were no
inclusions for the emergency-department setting.
c Only one child with RVGE was included from the primary-care setting in Sweden.
Table 4 Self-reported levels of stress experienced by
parents of children with rotavirus-positive
gastroenteritis; mean values and standard deviation on a
visual analogue scale where 1 = no stress and 10 =
extremely stressed.
Study area Parent Mean level of stress (standard deviation)
Hospital Emergency
department
Primary
care
Belgium Mother 7.44
(1.93)
4.5 (4.95) 6.57 (2.24)
Father 6.79
(2.38)
4.5 (4.95) 6.40 (2.72)
France Mother 8.27
(1.51)
7.10 (2.43) 5.82 (2.38)
Father 6.90
(2.09)
6.09 (2.61) 5.09 (2.40)
Germany Mother 8.53
(1.80)
–
a 6.57 (2.29)
Father 7.40
(2.85)
–
a 5.71 (2.55)
Italy Mother 7.53
(2.37)
7.71 (2.14) 5.46 (2.61)
Father 7.25
(2.46)
6.85 (2.42) 4.83 (2.46)
Spain Mother 8.99
(1.37)
8.64 (1.45) 7.18 (2.06)
Father 8.56
(1.53)
8.31 (1.76) 6.61 (2.33)
Sweden Mother 6.71
(2.23)
6.52 (2.46) 8.00
b
Father 5.30
(2.45)
5.77 (2.68) 7.00
b
United
Kingdom
Mother 8.89
(1.54)
7.44 (2.03) 8.40 (1.35)
Father 7.45
(2.68)
6.63 (2.29) 7.75 (1.75)
a In the German study area, all eligible children who presented to the
emergency department with acute gastroenteritis during the study were
referred to the hospital, so there were no inclusions for the emergency-
department setting.
b Only one child with RVGE was included from the primary-care setting in Sweden.
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been influenced by wide ranges in the observed data.
A previous analysis of data collected during the
REVEAL study demonstrated the substantial economic
burden of RVGE from the health-care and societal per-
spectives [11]. That analysis found that a considerable
proportion of the societal costs were attributable to loss
of productivity due to absenteeism by parents or other
carers, while the child was ill. It was also clear that the
loss of income caused by an absence of up to 7 working
days also represented a considerable financial burden for
the child’s family [11]. The requirements for additional
childcare and the substantial increase in the use of nap-
pies that we have identified in the present study would
further add to the costs of RVGE for the family. We
have also reported previously that a substantial propor-
tion of children with RVGE included in the REVEAL
study visited more than one health-care setting during
their illness [10]. Of children who first consulted in the
primary-care setting, 33-68% subsequently required
medical care in another clinical setting. This additional
demand upon parents may represent a further logistical
and financial burden.
Our results also show that paediatric RVGE caused
considerable stress for parents. In general, both fathers
and mothers rated their level of stress during the epi-
sode of illness as > 5 on the 10-point scale, regardless of
the setting in which the child was treated (although
stress among parents of children managed in hospital
tended to be higher). This is consistent with the results
of a small study performed in the USA, in which parents
of children with RVGE managed in either the emer-
gency department or hospital setting reported that their
child’s illness had caused them stress, anxiety, loss of
sleep and inconvenience (absence from work, increased
use of nappies) and disrupted normal family life [15].
There are very few data available regarding the impact
of acute childhood illnesses on family life. However, a
recent study of the burden of rotavirus diarrhoea among
children attending day-care centres in Lyon, France,
found that in 58% of cases of RVGE at least one parent
was required to take leave of absence from work (mean,
approximately 2 days) [16]. Similarly, a study of RVGE
in Belgium found that parents missed a mean of 1.5
days of work for cases managed in primary care and 2.5
days for hospitalised cases [13]. These findings are con-
sistent with observations made in the present study. To
put this in context with other childhood illnesses, a
study of children with acute otitis media in Israel found
that the mean number of working days lost by parents
was 1.6 ± 1.8 days [17] compared with means of 2 to 7
days in the present study.
Conclusions
The REVEAL study has provided valuable information
about the substantial economic burden, stress and dis-
ruption for families caused by community-acquired pae-
diatric RVGE. As a result of RVGE, parents or other
carers typically lost time from work, and additional
childcare arrangements were also required for up to a
quarter of cases. The use of nappies doubled during the
period that the child was ill. Taken together with con-
cern about their child, these effects undoubtedly con-
tributed to the high levels of stress reported by parents
as a result of the episode of RVGE.
The burden of RVGE on society, health-care systems,
children and their families could be substantially
reduced by routine rotavirus vaccination of infants.
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